Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 24;19(1):249.
doi: 10.1186/s12913-019-4055-8.

Developing a toolkit to implement the Statin Choice Conversation Aid at scale: application of a work reduction model

Affiliations

Developing a toolkit to implement the Statin Choice Conversation Aid at scale: application of a work reduction model

Aaron L Leppin et al. BMC Health Serv Res. .

Abstract

Background: Guidelines recommend shared decision making (SDM) for determining whether to use statins to prevent cardiovascular events in at-risk patients. We sought to develop a toolkit to facilitate the cross-organizational spread and scale of a SDM intervention called the Statin Choice Conversation Aid (SCCA) by (i) assessing the work stakeholders must do to implement the tool; and (ii) orienting the resulting toolkit's components to communicate and mitigate this work.

Methods: We conducted multi-level and mixed methods (survey, interview, observation, focus group) characterizations of the contexts of 3 health systems (n = 86, 84, and 26 primary care clinicians) as they pertained to the impending implementation of the SCCA. We merged the data within implementation outcome domains of feasibility, appropriateness, and acceptability. Using Normalization Process Theory, we then characterized and categorized the work stakeholders did to implement the tool. We used clinician surveys and IP address-based tracking to calculate SCCA usage over time and judged how stakeholder effort was allocated to influence outcomes at 6 and 18 months. After assessing the types and impact of the work, we developed a multi-component toolkit.

Results: At baseline, the three contexts differed regarding feasibility, acceptability, and appropriateness of implementation. The work of adopting the tool was allocated across many strategies in complex and interdependent ways to optimize these domains. The two systems that allocated the work strategically had higher uptake (5.2 and 2.9 vs. 1.1 uses per clinician per month at 6 months; 3.8 and 2.1 vs. 0.4 at 18 months, respectively) than the system that did not. The resulting toolkit included context self-assessments intended to guide stakeholders in considering the early work of SCCA implementation; and webinars, EMR integration guides, video demonstrations, and an implementation team manual aimed at supporting this work.

Conclusions: We developed a multi-component toolkit for facilitating the scale-up and spread of a tool to promote SDM across clinical settings. The theory-based approach we employed aimed to distinguish systems primed for adoption and support the work they must do to achieve implementation. Our approach may have value in orienting the development of multi-component toolkits and other strategies aimed at facilitating the efficient scale up of interventions.

Trial registration: ClinicalTrials.gov NCT02375815 .

Keywords: Implementation; Implementation strategies; Implementation toolkit; Scale-up; Shared decision making; Spread; Statin choice conversation aid; Statin choice decision aid; Statins.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study was approved by the Mayo Clinic Institutional Review Board and all participants gave consent to participate in this study. The reference number for the study is: 14–006048.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Study flow diagram (steps 5 and 6 are hypothetical and were not the focus of this work)
Fig. 2
Fig. 2
Conceptual rationale
Fig. 3
Fig. 3
Average monthly per clinician SCCA usage over time across the 3 health systems

Similar articles

Cited by

References

    1. Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S49–S73. doi: 10.1161/01.cir.0000437741.48606.98. - DOI - PubMed
    1. Stone Neil J., Robinson Jennifer G., Lichtenstein Alice H., Bairey Merz C. Noel, Blum Conrad B., Eckel Robert H., Goldberg Anne C., Gordon David, Levy Daniel, Lloyd-Jones Donald M., McBride Patrick, Schwartz J. Sanford, Shero Susan T., Smith Sidney C., Watson Karol, Wilson Peter W. F. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Circulation. 2013;129(25 suppl 2):S1–S45. doi: 10.1161/01.cir.0000437738.63853.7a. - DOI - PubMed
    1. Montori VM, Breslin M, Maleska M, Weymiller AJ. Creating a conversation: insights from the development of a decision aid. PLoS Med. 2007;4(8):e233. doi: 10.1371/journal.pmed.0040233. - DOI - PMC - PubMed
    1. Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, Christianson TJ, Mullan RJ, Smith SA. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167(10):1076–1082. doi: 10.1001/archinte.167.10.1076. - DOI - PubMed
    1. Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T. The statin choice decision aid in primary care: a randomized trial. Patient Educ Couns. 2010;80(1):138–140. doi: 10.1016/j.pec.2009.10.008. - DOI - PubMed

Substances

Associated data